Hemostatic Effects of Glucono-Delta-Lactone
Glucono-delta-lactone (GDL) can be used to mediate the human blood coagulation process. In particular, GDL can be used in an assay to determine an individual's risk potential for accelerated blood clotting or as a treatment for conditions related to accelerated clotting potential and/or inflammatory states.
Patents:US 20,110,071,219
Inventor(s):
SPILLERT CHARLES R [US]; PERSAUD DEBBIE [US]
Type of Offer:
Licensing
« More Medical Patents